DailyDoctor Archive Specialties Get app
All radiology briefings

The edition · Radiology

AI reading of non-contrast CT flags more large vessel occlusions than human readers — as a prompt, not a verdict

A network meta-analysis puts AI sensitivity for LVO at 78% against about 60% for readers, PI-QUAL makes prostate MRI quality something to report, and a biopsy trial finds the diagnosis, not the needle, drives quality of life.

The edition in brief

A Bayesian network meta-analysis of 10 retrospective validation studies (3,632 patients) found imaging AI detected anterior circulation large vessel occlusion on non-contrast CT with sensitivity 0.78 against 0.62 for expert and 0.60 for non-expert readers, with similar specificity around 0.86–0.88. Certainty was low and no study measured time to reperfusion or outcome, so AI belongs as an escalation prompt towards CT angiography or tele-stroke review, not as a rule-out. In the DEPROMP trial of 230 biopsy-naive men, combined systematic, MRI-targeted and PSMA PET-targeted transrectal biopsy had low morbidity, and worse quality of life at six months was attributed to the cancer diagnosis, not the biopsy. In the UK Lung Cancer Screening trial, an AI system matched 83.5% of persisting nodules across scans automatically, and only 1.5% of real nodules needed manual correction. An AJR expert panel sets out a practical approach to breast cancer risk assessment for screening. The practice-changer: an AJR special series review sets out how to put PI-QUAL image-quality scoring into routine prostate MRI, because poor-quality scans increase equivocal PI-RADS reports and weaken the pathway that depends on them.

In this edition
01
Clinical update

AI on non-contrast CT detects more large vessel occlusions than readers, on low-certainty evidence

Treat an AI large vessel occlusion flag on non-contrast CT as a reason to escalate, and a negative flag as no reason to stop.

1 min · Journal of medical Internet researchRead →
Primary outcome
Sensitivity and specificity for large vessel occlusion on non-contrast CT
Effect
AI sensitivity 0.78 (0.68 to 0.86) vs experts 0.62 (0.48 to 0.75); specificity 0.88 vs 0.86
02Research

Combined MRI- and PSMA PET-targeted prostate biopsy is well tolerated; the diagnosis drives quality of life

Multimodal targeted prostate biopsy is safe; put counselling effort into the diagnosis, not the procedure.

1 min · World journal of urologyRead →
03Research

AI matches lung screening nodules across scans reliably; only 1.5% needed manual correction

AI nodule matching can take most of the tracking workload in lung screening; keep manual review for high nodule counts.

1 min · European radiologyRead →
04Clinical update

An AJR expert panel sets out how to fold breast cancer risk assessment into screening

Make structured breast cancer risk assessment a routine step in screening, and match screening intensity to the result.

1 min · AJR. American journal of roentgenologyRead →
05Pearl

Say when the prostate MRI is not good enough

A PI-RADS score from a poor-quality scan should come with a statement that quality was poor.

1 minRead →
06Practice changer

Score and report prostate MRI quality with PI-QUAL

Report PI-QUAL alongside PI-RADS so every prostate MRI states whether it is good enough to act on.

1 min · AJR. American journal of roentgenologyRead →

Read the rest in the app

You have read your two free briefings this month. The app carries all 27 specialties, every morning, free — and this one is waiting in it.

QR code to install Daily Doctor
Get Daily Doctor — free

Scan to keep reading on your phone. No account needed to start.

Tomorrow morning, before your first patient

One edition a day for radiology, written by the desk, every claim tied to its paper. Six minutes.

Get the app — free